Overview
Izumi Ohigashi practices practicing medicine in Tokushima, Japan.
Ms. Ohigashi is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Myasthenia Gravis, Dacryoadenitis, and Thymectomy.
She is actively involved in clinical research, co-authoring 56 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Izumi Ohigashi
Is Izumi Ohigashi a top-rated expert for Myasthenia Gravis?
MediFind is an objective health platform that identifies experts based on real-world data. Izumi Ohigashi is classified as an Advanced expert for Myasthenia Gravis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Izumi Ohigashi participate in research or clinical trials?
Yes. Izumi Ohigashi has published 56 articles and abstracts on conditions like Myasthenia Gravis. You can view a list of Izumi Ohigashi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Myasthenia GravisMs. Ohigashi isAdvanced. Learn about Myasthenia Gravis.
- Experienced
- DacryoadenitisMs. Ohigashi isExperienced. Learn about Dacryoadenitis.
- ThymectomyMs. Ohigashi isExperienced. Learn about Thymectomy.